8 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... on GDMT, with or ... #inhibitors #EBM
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy
 • Beta-blocker
 • ACE,
Ejection Fraction (HFrEF ... ARNI • MRA • SGLT ... #Failure #CHF #HFrEF ... Guideline #management #GDMT
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy - Initiation Strategies

 •
Ejection Fraction (HFrEF ... Beta-Blocker → MRA → SGLT ... Beta-Blocker + SGLT ... #Failure #CHF #HFrEF ... Guideline #management #GDMT
Guidelines Directed medical therapy for Heart Failure 

Satyendra Dhar, MD, @DharSaty

#HFrEF #GDMT #sodium-glucosecotransporter-2inhibitors #SGLT2i #reninangiotensinaldosteronesysteminhibitors
@DharSaty #HFrEF ... #GDMT #sodium-glucosecotransporter ... -2inhibitors #SGLT2i
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Medical Therapy (GDMT ... ) in HFrEF and CKD ... GDMT across the ... diuretics, MRA, SGLT2i ... GDMT after core
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
resynchronization therapy; DM ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... Stages #ACCAHA #Algorithm
Idiopathic Inflammatory Myopathies - 
Dermatomyositis (DM), Immune-Mediated Necrotizing Myopathy (IMNM), Antisynthetase Syndrome (ASS), Inclusion Body Myositis
Dermatomyositis (DM ... Body Myositis (IBM ... Comparison #Managment #algorithm
Acute Kidney Injury (AKI) - Differential Diagnosis Framework
Pre-Renal:
 • Hypovolemia, Cardiorenal, Distributive Shock, HRS, Hypercalcemia, Renal
GN: ANCA, Anti-GBM ... Bladder (Medication, DM ... nephrology #causes #algorithm